/Mettler-Toledo%20International%2C%20Inc_%20logo%20and%20phone%20-by%20IgorGolovniov%20via%20Shutterstock.jpg)
Mettler-Toledo International Inc. (MTD), headquartered in Columbus, Ohio, manufactures and supplies precision instruments and services for laboratory, industrial, and food retailing applications. Valued at $26.6 billion by market cap, the company also supplies several related analytical and measurement technologies.
Shares of this leading supplier of precision instruments have underperformed the broader market over the past year. MTD has declined 9.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 15.1%. In 2025, MTD stock is up 5%, compared to the SPX’s 9.9% rise on a YTD basis.
Narrowing the focus, MTD’s underperformance is also apparent compared to the First Trust Indxx Global Medical Devices ETF (MDEV). The exchange-traded fund has declined about 4.1% over the past year. However, MTD’s single-digit returns on a YTD basis outshine the ETF’s marginal dip over the same time frame.
On Jul. 31, MTD shares closed down more than 2% after reporting its Q2 results. Its adjusted EPS of $10.09 topped Wall Street expectations of $9.58. The company’s revenue was $983.2 million, beating Wall Street forecasts of $957.6 million. The company expects full-year adjusted EPS in the range of $42.10 to $42.60.
For the current fiscal year, ending in December, analysts expect MTD’s EPS to grow 2.2% to $42.03 on a diluted basis. The company’s earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters.
Among the 13 analysts covering MTD stock, the consensus is a “Moderate Buy.” That’s based on five “Strong Buy” ratings, and eight “Holds.”
This configuration is more bullish than three months ago, with four analysts suggesting a “Strong Buy.”
On Aug. 4, Patrick B Donnelly from Citigroup Inc. (C) maintained a “Buy” rating on MTD with a price target of $1,400, implying a potential upside of 9% from current levels.
The mean price target of $1,330.45 represents a 3.6% premium to MTD’s current price levels. The Street-high price target of $1,600 suggests an upside potential of 24.5%.
On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
